| Drug Name | Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) |
|---|---|
| Drug Class |
Anti-hypertension
|
| Risk minimization type | |
| Specialty (Theraputic area) |
Cardiology
|
| Risk |
Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) in Patients with COVID-19 |
| safety communication |
|